Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-22-002328

Chief Commercial Officer acquired 2,509 shares (grant or award)

  • Chief Commercial Officer gave up 544 shares (to pay taxes)
  • Chief Commercial Officer acquired 995 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moat Ross · Chief Commercial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-15 Grant or award : show line 1 in the form +963 $11.49 $11,065 4,345 D
2022-01-15 Grant or award : show line 2 in the form +1,546 $9.63 $14,888 5,891 D
2022-03-16 Exercise or conversion : show line 3 in the form +995 6,886 D
2022-03-16 Shares withheld for taxes : show line 4 in the form −544 $10.13 $5,511 6,342 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-16 Exercise or conversion : show line 5 in the form Restricted Share Unit −995 2,982 D
Loading xslF345X03/edgar.xml…